公开(公告)号：EP3805389A1

公开(公告)日：2021-04-14

申请号：EP19811934.9

申请日：2019-05-30

申请人： Daiichi Sankyo Company, Limited ,  The University of Tokyo

发明人： MIYAKE, Kensuke ,  MURAKAMI, Yusuke ,  MOTOI, Yuji ,  KANNO, Atsuo ,  SHIMIZU, Toshiyuki ,  OHTO, Umeharu ,  SHIMOZATO, Takaichi ,  MANNO, Atsushi ,  KAGARI, Takashi ,  ISHIGURO, Jun ,  NAKAMURA, Kensuke ,  ISOBE, Takashi

IPC分类号： C12N15/13 ,  A61K39/395 ,  A61P29/00 ,  A61P31/00 ,  A61P35/00 ,  A61P37/00 ,  C07K16/28 ,  C07K16/46 ,  C12N1/15 ,  C12N1/19 ,  C12N5/10 ,  C12N15/63 ,  C12P21/08

摘要： The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.